| Anti-PL-7 (Anti-Threonyl-tRNA Synthetase) Antisynthetase Syndrome: Clinical Manifestations in a Series of Patients From a European Multicenter Study (EUMYONET) and Review of the Literature. | |
| | |
MedLine Citation:
|
PMID: 22732951 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
ABSTRACT: Autoantibodies against several aminoacyl-transfer-RNA synthetases have been described in patients with myositis; anti-threonyl-tRNA synthetase (anti-PL-7) is one of the rarest. We describe the clinical and laboratory characteristics of a cohort of European anti-PL-7 patients, and compare them with previously reported cases. This multicenter study of patients positive for anti-PL-7, identified between 1984 and 2011, derives from the EUMYONET cohort. Clinical and serologic data were obtained by retrospective laboratory and medical record review, and statistical analyses were performed with chi-squared and Fisher exact tests.Eighteen patients, 15 women, were anti-PL-7 antibody positive. Median follow-up was 5.25 years (interquartile range, 2.8-10.7 yr), and 4 patients died. All patients had myositis (12 polymyositis, 5 dermatomyositis, and 1 amyopathic dermatomyositis), 10 (55.6%) had interstitial lung disease, and 9 (50%) had pericardial effusion. Occupational exposure to organic/inorganic particles was more frequent in patients with interstitial lung disease than in the remaining patients (5 of 10 vs. 1 of 7; p = 0.152), although the difference was not significant. Concurrent autoantibodies against Ro60 and Ro52 were seen in 8 of 14 (57%) patients studied. In the literature review the most common manifestations of anti-PL-7 antisynthetase syndrome were interstitial lung disease (77%), myositis (75%), and arthritis (56%). As in other subsets of the antisynthetase syndrome, myositis and interstitial lung disease are common features of the anti-PL-7 antisynthetase syndrome. In addition, we can add pericarditis as a possible manifestation related to anti-PL-7 antibodies. |
| | |
Authors:
|
Ane Labirua-Iturburu; Albert Selva-O'Callaghan; Melinda Vincze; Katalin Dankó; Jiri Vencovsky; Benjamin Fisher; Peter Charles; Maryam Dastmalchi; Ingrid E Lundberg |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-6-22 |
Journal Detail:
|
Title: Medicine Volume: - ISSN: 1536-5964 ISO Abbreviation: - Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-6-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2985248R Medline TA: Medicine (Baltimore) Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
From the Internal Medicine Department (AL-I, AS-O), Vall d'Hebrón General Hospital, Universitat Autònoma de Barcelona and Vall d'Hebrón Research Institute, Barcelona, Spain; 3rd Department of Internal Medicine (MV, KD), Division of Immunology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary; Institute of Rheumatology (JV), Charles University, Prague, Czech Republic; Kennedy Institute of Rheumatology (BF, PC), Imperial College London, London, UK; Rheumatology Unit (MD, IEL), Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies: Report of 2 Cases and Review of...
Next Document: Morbidity and Impaired Quality of Life 30 Months After Chikungunya Infection: Comparative Cohort of ...